Neurocrine Biosciences
NBIX
#1491
Rank
NZ$25.98 B
Marketcap
NZ$255.65
Share price
-0.72%
Change (1 day)
11.78%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Stock price history for Neurocrine Biosciences (NBIX)

Highest end of day price: NZ$311.44 NZD on 2026-07-30

Lowest end of day price: NZ$3.36 NZD on 2009-11-12

Stock price history of Neurocrine Biosciences from 1996 to 2026

Annual Stock Price Performance

Year Performance
2026 8.14%
2025 2.88%
2024 3.62%
2023 9.73%
2022 35.01%
2021-11.16%
2020-11.50%
2019 53.36%
2018-9.95%
2017 100.70%
2016-26.07%
2015 147.68%
2014 133.93%
2013 14.74%
2012-12.51%
2011 10.82%
2010 184.01%
2009-16.82%
2008-29.20%
2007-55.79%
2006-83.61%
2005 27.97%
2004-11.17%
2003 20.11%
2002-9.71%
2001 59.41%
2000 31.84%
1999 260.00%
1998-17.29%
1997-17.65%
1996-20.00%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
NZ$47.61-0.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$441.87-0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2,003-3.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$303.91-0.37%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.02267-33.50%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$127.72 0.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.41 2.07%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$103.79-0.41%๐Ÿ‡ฌ๐Ÿ‡ง UK